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Phosphoinositide–AP-2 Interactions Required for Targeting to Plasma
Membrane Clathrin-coated Pits
Ibragim Gaidarov and James H. Keen
Kimmel Cancer Institute and the Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia,
Pennsylvania 19107

Abstract. The clathrin-associated AP-2 adaptor protein
is a major polyphosphoinositide-binding protein in
mammalian cells. A high affinity binding site has previously been localized to the NH2-terminal region of the
AP-2 a subunit (Gaidarov et al. 1996. J. Biol. Chem.
271:20922–20929). Here we used deletion and sitedirected mutagenesis to determine that a residues
21–80 comprise a discrete folding and inositide-binding
domain. Further, positively charged residues located
within this region are involved in binding, with a lysine
triad at positions 55–57 particularly critical. Mutant
peptides and protein in which these residues were
changed to glutamine retained wild-type structural and
functional characteristics by several criteria including
circular dichroism spectra, resistance to limited proteol-

ysis, and clathrin binding activity. When expressed in intact cells, mutated a subunit showed defective localization to clathrin-coated pits; at high expression levels,
the appearance of endogenous AP-2 in coated pits was
also blocked consistent with a dominant-negative phenotype. These results, together with recent work indicating that phosphoinositides are also critical to liganddependent recruitment of arrestin-receptor complexes
to coated pits (Gaidarov et al. 1999. EMBO (Eur. Mol.
Biol. Organ.) J. 18:871–881), suggest that phosphoinositides play a critical and general role in adaptor incorporation into plasma membrane clathrin-coated pits.
Key words: clathrin • adaptor • phosphatidylinositols •
endocytosis • adaptins

1. Abbreviations used in this paper: AP, assembly or associated protein;
CD, circular dichroism; MBP, maltose-binding protein; PH, pleckstrin homology; PPI, polyphosphoinositide or inositol polyphosphate.

and a and b in AP-2), a medium subunit (m1 in AP-1 and
m2 in AP-2), and a small subunit (s1 in AP-1 and s2 in
AP-2). The a subunits have some homology to the g subunit and both are very distantly related to the b/b9 subunits (reviewed in Keen, 1990; Schmid, 1997).
AP-2 is critical for two of the key functions of the early
steps of the endocytosis pathway: the formation of the
clathrin lattice and selection of specific cargo proteins for
internalization. AP-2 interacts with clathrin through the a
and b subunits (Goodman and Keen, 1995; Shih et al.,
1995) and promotes coat formation (Prasad and Keen,
1991). Interaction of the AP-2 m subunit with receptors
containing tyrosine-based internalization motifs contributes to their localization to coated pits (Ohno et al., 1995;
Sorkin et al., 1995; Boll et al., 1996; Heilker et al., 1996;
Shiratori et al., 1997), and there is evidence that AP-2 may
interact with other classes of internalization signals as well
(Rapoport, 1998; Rodionov and Bakke, 1998).
The function of AP-2 in endocytosis is probably modulated by multiple factors. Protein–protein interactions of
AP-2 with other macromolecules implicated in the endocytosis pathway such as dynamin (Wang et al., 1995),
synaptotagmin (Zhang et al., 1994), amphiphysin (David
et al., 1996), Eps15 (Benmerah et al., 1996; Iannolo et al.,
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endocytosis is a multistep process by which certain cell surface proteins are
specifically and efficiently internalized into cells
through plasma membrane coated pits. Clathrin, the major
structural component of the cell surface coated pit, is a
triskelion-shaped protein that forms the regular polygonal surface lattice of the coat and provides its structural
integrity. Another stoichiometric component of the coat
is the multimeric protein complex termed adaptor or AP1,
for assembly or associated proteins. Most of the APs are
heterotetrameric proteins and multiple forms have been
identified (reviewed in Schmid, 1997). The best characterized of these are the AP-1 and AP-2 proteins, which are
involved in clathrin coat formation and sorting at the
Golgi and plasma membrane, respectively. These AP
molecules consist of two large subunits (g and b9 in AP-1

R
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1997), and Shc (Okabayashi et al., 1996) have been identified. In addition, AP-2 has also been shown to bind with
high affinity to certain polyphosphoinositides and inositol
polyphosphates (collectively referred to here as PPI)
(Beck and Keen, 1991; Timerman et al., 1992; Voglmaier
et al., 1992; Gaidarov et al., 1996). In recent years polyphosphoinositides have been implicated in different vesicular trafficking events. In yeast, the VPS34 protein, a homologue of a catalytic subunit of a mammalian PI-3
kinase, has been shown to be required for the sorting of
newly synthesized vacuolar enzymes from the Golgi to the
vacuole (Schu et al., 1993; Stack et al., 1993; Stack and Emr,
1994). In mammalian cells, a similar trafficking route from
the Golgi to lysosomes was blocked by wortmannin, a potent inhibitor of PI-3 kinase (Brown et al., 1995; Davidson,
1995). PI-3 kinase has also been implicated in the endocytosis (Gommerman et al., 1997) or postendocytic trafficking
(Joly et al., 1994, 1995) of growth factor receptors and in
the formation of constitutive exocytic vesicles at the Golgi
(Jones and Howell, 1997). Additionally, phosphoinositides
were shown to be involved in endocytic coated vesicle formation and endosomal membrane targeting of AP-2 in an
in vitro system (West et al., 1997; Jost et al., 1998). Finally,
many proteins involved in endocytosis either bind PPIs
(AP-2 [Beck and Keen, 1991; Gaidarov et al., 1996]; synaptotagmin [Niinobe et al., 1994; Schiavo et al., 1996]; AP180
[Ye et al., 1995; Hao et al., 1997]; dynamin [Salim et al.,
1996; Zheng et al., 1996; Barylko et al., 1998]), or are involved in their metabolism (synaptojanin [McPherson et
al., 1996; Haffner et al., 1997; Woscholski et al., 1997]).
In previous reports we identified and characterized high
affinity, stoichiometric binding of various PPIs to AP-2
(Beck and Keen, 1991), and determined that AP-2 in an
assembled coat structure had unique PPI binding properties, exhibiting a preference for phosphoinositides over
inositol polyphosphates (Gaidarov et al., 1996). Initial
studies also indicated that comparatively high concentrations of PPIs (z20–50 mM) could inhibit AP-mediated
coat assembly (Beck and Keen, 1991). Related effects
have been observed in studies of the arrestin–clathrin interaction (Gaidarov et al., 1999). In both cases, a high affinity PPI binding site (KD # 0.1 mM), which is the focus of
this report, appears not be involved. We were subsequently able to localize the PPI binding site to the NH2terminal amino acids 5 to 80 of the a subunit of AP-2 (Gaidarov et al., 1996), a region that is identical at the amino
acid level in the cognate aA and aC genes (Robinson,
1989). Taking into account this inositide specificity and the
findings described above, we speculated that the interaction of PPIs with AP-2 could be important in its role in formation of plasma membrane clathrin-coated pits and/or in
the recruitment of receptors. In this study we investigated
this hypothesis in intact cells using a mutagenesis and intact cell expression approach. Our results indicate that a
functional PPI binding site is indeed necessary for AP-2
recruitment to sites of clathrin-coated pit formation.

Materials and Methods

(Keen, 1987). D-myo-Inositol hexakiphosphate (IP6) was obtained from
Calbiochem. [3H]IP6 was from DuPont NEN, 35S-Translabel was from
ICN. L-1-Tosylamido-2-phenylethyl chloromethyl ketone-trypsin was
from Worthington Biochemical, Inc. Restriction and modification enzymes were purchased from Boehringer Mannheim. S-Sepharose and
Sepharose 2B were from Sigma Chemical Co. TnT rabbit reticulocyte
transcription-translation system was from Promega. All other chemicals
were reagent grade or better and were purchased from Sigma Chemical
Co. or Fisher.

Construction of Deletion and Site Mutants in
Maltose-binding Protein a5-80
Deletion and site-directed mutations in the a5-80 insert in the plasmid
pMAL aA5-80 (Gaidarov et al., 1996) were performed using a combination of subcloning procedures and polymerase chain reaction. Details of
these procedures are available upon request. The fusion proteins were expressed and purified as described previously (Gaidarov et al., 1996).

Preparation of Wild-type and Mutant a5-80 Peptides
Purified maltose-binding protein chimera were dialyzed into 20 mM TrisHCl, pH 8.0, 100 mM NaCl, and 2 mM CaCl2, and digested with the Factor
Xa (1 mg enzyme/200 mg fusion protein) for 24–36 h at 48C. The digestion
mixture was then incubated with amylose beads to remove MBP and undigested fusion protein. The supernatant was then applied to an S-Sepharose column (Pharmacia) and the column was washed with 20 mM sodium phosphate, pH 7.3, 200 mM NaF. The bound peptide was eluted with
20 mM sodium phosphate and 1 M NaF. The eluate was dialyzed into 10
mM sodium phosphate, pH 7.3, and 100 mM NaF, and used for circular
dichroism spectroscopy. Purity of the peptide was checked by SDS-electrophoresis on an 8–25% gradient gel using a PhastSystem (Pharmacia).

Inositol Polyphosphate–binding Assay
The binding of [3H]IP6 to recombinant fusion proteins was determined by
a polyethylene glycol precipitation procedure as described previously
(Gaidarov et al., 1996).

Circular Dichroism Spectroscopy
Circular dichroism (CD) spectroscopy was performed on an Aviv-62DS
instrument at ambient temperature under nitrogen atmosphere with peptides at 0.1–0.4 mg/ml in 10 mM sodium phosphate, 100 mM NaF. The CD
spectra were analyzed using secondary structure prediction software
based on the method described by Andrade et al. (1993).

In Vitro Transcription-Translation of Wild-type and
Mutant AP-2aA
Wild-type and mutant aA subunits were expressed in vitro using a TnT
rabbit reticulocyte lysate transcription-translation system. First, plasmid
pSP65aA (Goodman and Keen, 1995) was modified to optimize expression by removing most of the 59 untranslated region beyond 10 bp upstream of the initiation codon of aA cDNA. Analysis showed that the
resulting plasmid pSP65aA2 gave 5–10-fold higher expression than
pSP65aA. Mutant aA cDNA fragments were cloned into the pSP65aA2 by
a series of subcloning procedures, the details of which are available on request. The resulting plasmid pSP65 aAKKK-Q and the plasmid pSP65aA2
were used for in vitro expression of mutant and wild-type aA.
Transcription-translation reactions were performed according to the
manufacturer’s recommendations in the presence of 35S-Translabel. After
incubation for 2 h at 308C, translation reactions were centrifuged at
100,000 rpm for 20 min at 48C in a TLA100 rotor (Beckman).

Proteolysis and Clathrin Cage Binding Assays of In
Vitro Translated a Polypeptides
Limited tryptic proteolysis and clathrin cage binding experiments with in
vitro–translated wild-type and mutant AP-2a polypeptides were performed essentially as described previously (Goodman and Keen, 1995).

Materials

Expression of Wild-type and Mutant Adaptin
Constructs in Mammalian Cells

Clathrin was purified from bovine brain–coated vesicles as described

Plasmid containing the aga construct (derived from bovine AP-2aC) in
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pBluescript SK2 (Robinson, 1993) was digested with EcoRI, treated with
Klenow fragment and dNTP, and subsequently digested with SacI. Excised fragments were ligated into the plasmid pSP65 that had been digested with SacI and SmaI, resulting in the plasmid pSP65-dN-aga. This
plasmid was cut with SacI and SalI, and the excised fragment was ligated
together with the linker connecting NdeI and SacI sites into the plasmids
pSP65aA2 and pSP65 aAKKK-Q from which NdeI-SalI fragments were
excised. The resultant plasmids pSP65-WTaga and pSP65-M18aga contained wild-type and mutant aga chimeric inserts. These plasmids were
consecutively treated with SalI, blunted with Klenow fragment and dNTP,
and then digested with EcoRI. The excised inserts were ligated into eukaryotic expression vector pcDNA3 that had been cut with EcoRI and
EcoRV, resulting in plasmid constructs pcDNA3agaWT and pcDNA3agaKKK-Q.
For transient expression, BALB/c-3T3 cells were grown in T-75 flasks
in a humidified atmosphere with 5% CO2 in DME supplemented with
5% fetal bovine serum, 5% calf serum, 100 U/ml penicillin, and 100 mg/ml
streptomycin. The cells were grown to 60–70% confluence and transfected
with expression constructs using Lipofectamine reagent. In brief, 15 mg of
pcDNA3agaWT or pcDNA3agaKKK-Q were incubated with 80 ml of
Lipofectamine in 5 ml of DMEM for 30 min at room temperature. After
the incubation 5 ml of DME was added and the mixture was transferred to
a flask with DMEM-rinsed BALB/c-3T3 cells. After 4 h of incubation the
mixture was substituted with complete media and the cells were incubated
for 15–18 h. Cells were then trypsinized and plated on 12-mm round glass
coverslips in a 24-well plate. Immunofluorescence analysis was performed
48 h after transfection.

Coimmunoprecipitation of b-Adaptin with
aga Polypeptides
MOP8 cells transiently transfected for 48 h with the wild-type aga or
KKK/Q mutant aga constructs (3 T-75 flasks) were washed with PBS
and scraped into 5 mM Tris-HCl, pH 7.0, supplemented with protease
inhibitors. After homogenization, 1 M Tris-HCl, pH 7.0, was added to
the broken cells to a final concentration of 0.5 M, the suspension was incubated for 30 min on ice and centrifuged at 100,000 rpm for 30 min in
TLA100 rotor (Beckman). The supernatant was diluted to yield a concentration of 125 mM Tris-HCl and supplemented with protease inhibitors and Triton X-100 (0.05%). The AP-2 aga protein was immunoprecipitated with the antibody 100/3 (Ahle et al., 1988) and resolved by
SDS-PAGE. Western blot analysis was performed using antibodies R2
and 100/3, specific for the b- (Voglmaier et al., 1992) and g-adaptins, respectively, as well as affinity-purified antibodies against m2 and s2 (Page
and Robinson, 1995).

Immunofluorescence Microscopy Analysis
Immunofluorescence analysis was performed as described previously
(Santini and Keen, 1996). In brief, cells were washed, fixed, permeabilized, and exposed to mouse monoclonal antibody 100/3 (50 mg/ml) for detection of aga polypeptide and rabbit Ab31 (1:150) for detection of endogenous AP-2 (Sorkin et al., 1995). We have found that Ab31, though it
was made against a fragment containing both the hinge and ear sequences
of rat brain aC, reacts only with a hinge and not with the ear domain (data
not shown). Treatment of the a subunit with trypsin is known to generate
two major fragments corresponding to the core and the intact hinge 1 ear
domains, while elastase cleaves the ear fragment leaving intact core 1
hinge (Wilde and Brodsky, 1996). On immunoblotting, Ab31 recognized
the intact hinge 1 ear domain generated by trypsin, but failed to recognize the separate ear domain produced by elastase. Antibody 100/2, specific for the a ear, recognized both the hinge 1 ear fragment generated by
trypsin and the ear domain generated by elastase. This allowed us to use
Ab 31 to detect endogenous a but not aga, which lacks the hinge region
of a.
Clathrin was detected using rabbit polyclonal antibody 27004 (1:150 dilution) (Willingham et al., 1981). Primary antibodies were detected with
fluorescein-conjugated donkey anti–mouse IgG or rhodamine-lissamine–
conjugated donkey anti–rabbit IgG secondary antibodies (Jackson ImmunoResearch). Confocal microscopy was performed on a Bio-Rad MRC600 laser scanning confocal microscope, using a Zeiss Plan-Apo 633 1.40
NA oil immersion objective. Images were collected sequentially in the
photon counting mode using single line excitation.
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Results
Dissection of the AP-2 a PPI Binding Site by
Truncation Mutagenesis
In our previous study, using photoaffinity labeling and
bacterially expressed fusion proteins, we localized the high
affinity PPI binding site on the clathrin adaptor protein
AP-2 to the region between residues 5 and 80 at the NH2terminal of the a subunit. To determine whether PPI binding could be localized to a shorter sequence within this region, we produced several maltose-binding protein (MBP)
fusion proteins containing smaller fragments (Fig. 1).
Among fusion proteins containing either residues 5–21,
21–80, 5–49, or 50–80, only those containing residues 21–80
retained specific IP6 binding, with affinity similar to that of
the full fragment 5–80 (Fig. 1); the other fusion proteins
did not display any detectable binding. This suggested that
the PPI binding site in the AP-2 a subunit may not be represented by a short stretch of residues, but that a relatively
large portion of the sequence between amino acids 21–80
may be required to form a discrete domain with proper
tertiary structure.

Site-directed Mutagenesis of the AP-2 a PPI
Binding Domain
The AP-2 a sequence between residues 5 and 80 is a fairly
basic region with several clusters of cationic residues. As it
is likely that positive charges are involved in the interaction with the negatively charged phosphate groups of PPIs,
we investigated more closely the role of these basic residues in IP6 binding. Accordingly, we produced a series of
fusion proteins of MBP with the AP-2 a5-80 fragment (denoted MBP-a5-80) in which each basic amino acid (10
lysines and 4 arginines) was changed to a glutaminyl residue. Glutamine was chosen because it contains a substantial side chain, similar to lysyl and arginyl residues, but is
uncharged. Each of these fusion proteins was purified by
affinity chromatography and tested for IP6 binding.
We found that residues scattered throughout the a 5–80
region affected IP6 binding, though to differing extents
(Fig. 2). The mutations could be divided into several
groups in terms of their effects on IP6 binding: no reduc-

Figure 1. A PPI binding site in the NH2-terminal region of AP-2
a. Indicated segments of the AP-2a sequence coupled at their
NH2 terminus to MBP were analyzed for [ 3H]IP6 binding and approximate binding affinity. A high affinity site is present within
residues 21–80, while shorter segments do not retain specific
binding activity.
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Figure 2. Site-directed mutagenesis of the PPI binding domain of
AP-2 a MBP fusion proteins containing the indicated residue alterations were expressed and tested for retention of [ 3H]IP6 binding. The lysine triad at positions 55–57 was most critical, and alteration to glutaminyl residues virtually abolished binding.

tion in IP6 binding activity (R21); slight (z20%) reduction
(K24, K26, R41, K43, K48); substantial (z40%) reduction
(K31, R32, K35, K45, K61); and large (.60%) inhibition
(K55, K56, K57). To investigate further the role of lysyl
residues 55–57 whose alteration to glutamines had the
most pronounced effect on IP6 binding, we generated an
additional mutant in which residue K56 was changed to
glutamic acid with reversal of charge. The IP6 binding ability of this mutant was even more greatly diminished, to
z30% of the wild-type protein, compared with substitution with glutamine. When all three lysyl residues were
changed to glutamines in a single mutant, denoted KKK/Q,
the IP6 binding ability was decreased to ,10% of the wildtype protein. This mutant, essentially devoid of IP6 binding, was characterized further using biophysical methods and functional assays described below to determine
whether these residues are directly involved in PPI binding, or whether the decrease in PPI binding is the result of
gross conformational change in the structure of the protein.

Figure 3. Secondary structure of the PPI binding domain of AP-2
a. (a) Circular dichroism spectrum in aqueous solution (solid
line) of the isolated wild-type AP-2 a5-80 fragment cleaved from
MBP reveals substantial secondary structure. In 50% trifluoroethanol (dashed line) it exhibits almost complete a-helical folding. (b) The circular dichroism spectra of the wild-type (solid
line) and KKK/Q mutant (dashed line) AP-2 a5-80 polypeptides
are virtually identical, consistent with retention of the secondary
structure present in the native structure.

CD spectroscopy is a very useful method for the rapid determination of secondary structures of peptides and proteins. We employed CD spectroscopy to characterize the
secondary structure of the AP-2 PPI binding domain and
to monitor any changes resulting from the mutations introduced in its sequence. The AP-2 a5-80 fragments of
the wild-type and KKK/Q mutant fusion proteins were
cleaved with Factor Xa and purified from MBP by consecutive affinity and ion-exchange chromatography steps as
described in Materials and Methods. The purification procedure resulted in peptide preparations that were uniformly .95% homogeneous (data not shown). A CD
spectrum of the isolated wild-type AP-2 a5-80 fragment is
shown in Fig. 3 a. The positive absorption peak at 195 nm
and two negative peaks at 207 and 222 nm indicate that

the conformation of the a5-80 peptide has substantial
a-helical content. Secondary structure calculated by the
method of Andrade et al. (1993) yielded estimates of z37%
a-helix and 26% b sheet. Also shown in Fig. 3 a is the CD
spectra of the wild-type AP-2 a5-80 fragment in 50% trifluoroethanol, known to induce an a-helical conformation
in oligopeptides (Sonnichsen et al., 1992). Under these
conditions, the spectrum of the wild-type fragment exhibited much more pronounced maximum and minima, corresponding to almost 100% a-helicity.
The CD spectrum of the mutant AP-2 a5-80-KKK/Q
fragment is presented in Fig. 3 b, along with the spectrum
of the wild-type peptide. The mutant a5-80-KKK/Q has
secondary structure content practically identical to that of
the wild-type protein. The CD spectrum of the purified
peptide derived from the charge inversion mutant AP-2
a5-80-K56E was also indistinguishable from that of the
wild-type (data not shown). These results argue that the
decrease in PPI binding observed with these mutants is not
the result of gross conformational changes induced by the
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Structural Analysis of the Wild-type and Mutant AP-2
a PPI Binding Domains by Circular
Dichroism Spectroscopy

amino acid substitutions, but rather results from disruption of direct interactions between the ligand and basic
residues on the protein.
We tried to determine whether ligand binding induces
any conformational change in the PPI binding domain a580. Unfortunately, in the presence of IP6 at concentrations
as low as 1 mM the peptide aggregated. This problem
could not be overcome by the addition of salt and/or nonionic detergents.

Structural and Functional Characterization of the
KKK/Q Mutant in the Context of the Full-length In
Vitro Translated AP-2 a Subunit
To further evaluate the effects of the KKK/Q mutation on
the overall properties of the AP-2a subunit, we performed
structural and functional assays on full-length wild-type
and mutant AP-2 a polypeptides generated in a rabbit
reticulocyte in vitro translation system. We have previously shown that the in vitro translated AP-2 a polypeptide is folded similarly to that in the native AP-2 complex
isolated from bovine brain (Goodman and Keen, 1995).
For example, limited tryptic proteolysis of in vitro–translated AP-2a generates fragments of z55–66 kD and 40 kD,
corresponding to the NH2-terminal core and COOH-terminal appendage domain generated on similar treatment
of the native bovine brain AP-2 (Zaremba and Keen,
1985). Similar limited proteolysis of in vitro translated mutant KKK/Q aA polypeptide produced a pattern with the
characteristic core and appendage domains, virtually identical to that of the wild-type polypeptide (Fig. 4 a). This
result demonstrates that alteration of the K(55-57) residues in the NH2-terminal region of the AP a polypeptide
does not cause gross misfolding of the entire subunit on
synthesis.
The isolated AP-2 a subunit generated by in vitro translation has also been shown to bind specifically to clathrin
(Goodman and Keen, 1995). This provided a useful assay
to ask whether lysyl residues 55–57 were directly involved
in clathrin binding, or whether their substitution with
glutamines altered structural properties of the isolated
AP-2 a polypeptide required for this interaction. We
found that binding of the in vitro–translated mutant KKK/Q
a polypeptide to clathrin cages was indistinguishable from
that of the wild-type polypeptide (Fig. 4 b). Collectively,
these results indicate that the mutant KKK/Q AP-2 a
polypeptide retained the native tertiary structure and
function of the wild-type protein, but that it is essentially
devoid of PPI binding ability.

Figure 4. AP-2 a and the KKK/Q mutant lacking PPI binding
have similar domain structure and clathrin binding activity. (a) In
vitro translated wild-type AP-2 a subjected to limited proteolysis
with 0, 50, 100, or 150 ng/ml trypsin (lanes 1–4, respectively) for
15 min at room temperature results in generation of fragments
corresponding to the 60–66-kD core (C) and 40-kD appendage
(A) domains, following preferential cleavage in the hinge region
as previously described (Goodman and Keen, 1995). The cleavage pattern of the mutant AP-2 a KKK/Q translation product is
virtually identical in terms of both protease sensitivity and fragments generated, indicating the presence of similar folded domains. (b) Most of input (I) of in vitro–translated wild-type AP-2
a binds to clathrin cages (30 mg) and becomes sedimentable in
their presence (1), while little sediments in their absence (2), as
previously reported (Goodman and Keen, 1995). The mutant
AP-2 a KKK/Q translation product shows essentially identical
behavior.

To investigate the functional role of the AP-2 PPI binding
site in intact cells, we employed an aga construct described previously (Robinson, 1993) and kindly provided
by Dr. M.S. Robinson (University of Cambridge). The
aga construct encodes mouse aC polypeptide in which the
hinge region between the core and appendage domains,
corresponding to aC residues 620–700, has been substituted with the hinge region of the bovine Golgi-specific
AP-1 g subunit. This enabled us to specifically localize the
expressed aga polypeptides in transiently transfected

mouse fibroblasts using a g-specific monoclonal antibody
(mAb 100/3) which does not recognize the endogenous
(mouse) protein (Ahle et al., 1988). Additionally, the endogenous AP-2 a polypeptide could also be uniquely localized using Ab31, a rabbit polyclonal anti-a antibody
kindly provided by Dr. A. Sorkin (University of Colorado). We found that though Ab31 was produced by inoculation with a fragment consisting of the hinge and appendage domains of the rat brain aC subunit (Sorkin et al.,
1995), it reacts only with the a hinge region and not with
the a appendage (see Materials and Methods). Thus, the
endogenous and the transiently expressed exogenous a
polypeptides could be detected independently, providing
important tools for the study of mutant a subunits.
First, we asked whether wild-type and KKK/Q mutant
AP-2 aga polypeptides expressed after transfection are incorporated into AP-2 adaptor complexes in intact cells.
Lysates of mock, wild-type aga, and KKK/Q mutant aga–
transfected MOP8 mouse fibroblasts were challenged with
monoclonal antibody 100/3, and the resultant immunoprecipitates were fractionated by SDS-PAGE and analyzed
by immunoblotting with antibodies to the other AP-2 subunits. As shown in Fig. 5, reactivity with the anti-g 100/3
antibody was detected only in immunoprecipitates from
cells transfected with the wild-type or mutant aga constructs, consistent with the inability of this antibody to recognize the endogenous mouse AP-2 g polypeptide. On im-
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Functional Characterization of Mutant KKK/Q AP-2 a
in Intact Cells

Figure 5. Wild-type and
mutant KKK/Q AP-2 a
polypeptides are associated
with AP-2 subunits in intact
cells. Equal amounts of lysates prepared under nondenaturing conditions from untransfected mouse MOP8
cells (mock) or cells transfected with either wild-type
AP-2 aga (wt) or mutant
aga (KKK/Q) cDNAs were immunoprecipitated (IP) with antibody 100/3, which recognizes only the bovine g hinge insert
present in the exogenous transiently expressed protein. Both the
wild-type and PPI binding defective KKK/Q mutant AP-2 a
polypeptides (revealed by blotting with anti-g antibodies) are incorporated into AP-2 complexes as revealed by immunoblotting
of the immunoprecipitates with anti-b, anti-m2, and anti-s2 antibodies.

munoblotting with antibodies to the b, m2, or s2 subunits
of AP-2, no signal was detected in the immunoprecipitates
from mock-transfected cell lysates demonstrating that recovery of the endogenous AP-2 subunits were dependent
on their incorporation into complexes containing exogenous aga polypeptide. However, anti-g immunoprecipitates of cells transfected with either the wild-type or the
KKK/Q aga constructs contained the endogenous b2, m2,
and s2 subunits in similar amounts. These findings confirm the results of Page and Robinson (1995) in indicating
that the wild-type aga polypeptide becomes incorporated
into AP-2 complexes, which we denote AP-2WT. Furthermore, the results presented here demonstrate that the mutant KKK/Q aga polypeptide behaves indistinguishably
from the wild-type, associating with the other AP-2 subunits and forming complexes (which we denote AP-2PPI2)
in the transiently transfected cells.

To investigate the cellular phenotype resulting from
knockout of the PPI binding site of AP-2, we analyzed
transfected BALB/c-3T3 cells by confocal fluorescence
microscopy. Though the transfection efficiency of BALB/
c-3T3 cells was lower than that of MOP-8 cells in our
hands, the former were chosen for this experiment because their morphology after fixation is much more
amenable to immunofluorescence analysis of plasma
membrane coated pits. Cells transfected with wild-type
(AP-2WT) or mutant KKK/Q (AP-2PPI2) aga constructs
were double-labeled with mouse monoclonal antibody
100/3 to reveal the localization of the exogenous aga
product, and with either rabbit Ab31 or 27004 to localize
endogenous a-adaptin or clathrin, respectively.
Fig. 6 a shows the localization of the AP-2WT aga product at several different expression levels in transiently
transfected cells. The vast majority of the expressed AP2WT protein (upper panels) had a punctate distribution in
the plane of the plasma membrane, with very little diffuse
signal detectable. Comparison with the distribution of endogenous AP-2 a (lower panels) indicated almost complete colocalization (Fig. 6 a). The images also show that
the presence of the g hinge did not misdirect the protein to
the Golgi region. Consistent with this finding, the AP-2WT
distribution was also largely coincident with the localization of plasma membrane coated pits stained with anticlathrin antibody, but did not colocalize with anti-clathrin
staining in the trans-Golgi network (data not shown). Similar observations were made by Robinson (1993) on her
initial use of the aga construct for expression in Rat1 cells.
At low expression levels, AP-2WT had no detectable effect on the distribution of the endogenous a adaptin (Fig.
6 a, left panels). Interestingly, in cells with higher levels of
expression there is an apparent dominant-negative effect
in that the level of endogenous a adaptin in clathrincoated pits is decreased compared with untransfected cells
in the same field (Fig. 6 a, center and right panels). Only at

Figure 6. AP-2WT, but not
AP-2PPI2, is targeted normally to clathrin-coated pits
at the plasma membrane. (a)
AP-2WT expressed in BALB/
c-3T3 cells exhibits a punctate
pattern entirely coincident
with that of endogenous AP-2
a and is localized to plasma
membrane clathrin-coated pits.
With increasing levels of aga
expression (right panels), the
incorporation of the endogenous AP-2 a polypeptide into
coated pits is diminished. (b)
Expressed AP-2PPI2 does not
colocalize with endogenous
AP-2 a in coated pits. With
increasing expression of AP2PPI2, correct localization of
endogenous AP-2 to plasma
membrane
clathrin–coated
pits is also impaired (right
panels). Bar, 10 mm.
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unphysiologically elevated levels of expression is there any
evidence for significant accumulation of soluble AP-2WT
protein (data not shown), and there is no detectable effect
on the normal distribution of clathrin at the plasma membrane or in the Golgi region.
The localization of the mutant AP-2PPI2 protein at several different levels of expression are shown in Figs. 6 b
and 7. The distribution of the mutant protein differed radically from that of the wild-type protein. Generally, most
of the AP-2PPI2 localization was diffuse and at any level of
expression, no significant amount of the mutant polypeptide could be detected in clathrin-coated pits at the plasma
membrane. In some cells a small amount of finely punctate
signal was detectable, most of which was intracellular.
With few exceptions this signal did not coincide with that
of endogenous AP-2 a (Fig. 6 b), nor did it colocalize with
either early or recycling endosomes (labeled with endocytosed fluorescent transferrin), or with the late endosome/
lysosomal compartment (labeled with endocytosed fluorescent dextran) (data not shown). Interestingly, with increasing expression levels of the mutant AP-2PPI2 protein,
the proper localization of AP-2 to discrete plasma membrane sites was diminished (Fig. 6 b, right panels).
Similarly, at low levels of mutant AP-2PPI2 expression,
the localization of clathrin to plasma membrane was not
noticeably affected (Fig. 7, left and middle panels). However, clathrin localization was clearly abnormal at higher
levels of mutant expression with a reduced number of
plasma membrane coated pits present in comparison to
adjacent, nonexpressing cells (Fig. 7, right panels). Interestingly, the clathrin signal in the Golgi region also seemed
to be affected by elevated levels of AP-2PPI2 expression,
consistent with continuity between the plasma membrane
and Golgi pools of clathrin.
Finally, we evaluated the internalization of the fluorescently tagged transferrin by cells expressing aga constructs. In cells expressing low levels of either the AP-2WT
or AP-2PPI2 mutant proteins, internalization of transferrin
was indistinguishable from that in neighboring cells that
were not expressing either product (data not shown), consistent with the absence of an effect on coated pit distribution in these cells. Interestingly, transferrin internalization
was greatly diminished in cells expressing moderate levels
of the mutant AP-2PPI2 protein, consistent with the disruption of clathrin-coated pits in that population. In contrast,
AP-2WT did not detectably affect transferrin uptake until
very high levels of expression were attained.

Figure 7. Clathrin distribution is normal at low expression levels
of AP-2PPI2, but is perturbed at higher levels. Bar, 10 mm.

In this study, we have sought to determine the importance
of the high affinity PPI binding site located in the NH2-terminal region of the AP-2a subunit in the process of receptor-mediated endocytosis. In previous reports we identified the polypeptide region involved in binding (Beck and
Keen, 1991; Gaidarov et al., 1996) and provided in vitro
evidence that PI-3,4,5-P3, a product of phosphatidylinositol 3-kinase, is the ligand of highest known affinity for AP-2
in assembled coat structures (Gaidarov et al., 1996).
Though these results suggested that PIP3 is a physiologically relevant ligand for AP-2, in the absence of definitive
data from intact cells this conjecture remains uncertain, as

does the precise identity of other ligand(s) that may interact with AP-2. Accordingly, we undertook a complementary approach to study the physiological function of the
AP-2 PPI binding site. We sought to identify and alter
amino acid residues critical for PPI binding to AP-2, and
to evaluate the effects of expression of this mutant AP-2 in
intact cells. The results of these efforts lead to the conclusion that an active PPI site is indeed required for AP-2
function in receptor-mediated endocytosis.
In some PPI-binding proteins short peptides (8–20 residues) have been found to be sufficient for high affinity
binding of inositol phosphates or phosphoinositides. Examples include certain actin-associated proteins such as
gelsolin (Janmey et al., 1992; Yu et al., 1992) and profilin
(Raghunathan et al., 1992; Sohn et al., 1995) and some
C2 domain–containing proteins such as synaptotagmin
(Fukuda et al., 1994, 1995). Pleckstrin homology (PH) domains, which are found in a number of proteins involved in
signal transduction and are believed to function in membrane recruitment and regulation of enzymatic activity
(Shaw, 1996; Fukuda and Mikoshiba, 1997; Lemmon and
Ferguson, 1998), provide a contrasting pattern. In these
proteins essentially the entire z100 amino acid module is
necessary for high affinity ligand binding.
The mutagenesis analysis reported here suggests that
the latter characterization is more applicable to the PPI
binding site in AP-2 a. It has a highly organized secondary
structure and seems to require a $60 residue region for
full binding activity, from which we infer that this portion
of the a structure comprises a distinct structural and functional domain. Positively charged amino acids throughout
the region contribute to the binding interaction (Fig. 2),
with two clusters of basic residues toward each end (a
lysine triad at 55–57 and K31/R32/K35) appearing to be
most important. In parallel with the PH domains whose
tertiary structure in complex with ligands has been determined (e.g., that in b-spectrin; Hyvonen et al., 1995), the
PPI binding region in AP-2 may be a large positively
charged surface with some residues in direct contact with
the bound ligand, while others may be responsible for the
initial electrostatic recruitment of the PPI to the binding
pocket or the formation of the charged surface. It is in-

Gaidarov and Keen Phosphoinositides and Coated Pit Targeting

761

Discussion

creasingly appreciated that protein domains may have remarkably similar three-dimensional structure but share
very limited sequence homology. Consequently, the relationship of the AP-2 binding site to other PPI binding domains with which it does not share detectable sequence
identity will probably only be answered after determination of its tertiary structure.
This region of the AP-2 a sequence, and the basic residues in particular, are virtually entirely conserved in both
Drosophila and C. elegans homologues of mammalian aA.
Furthermore, although the overall identity of two recently
identified yeast a homologues with the mammalian protein in this region is 30–40%, most of the basic residues required for inositide binding in the mammalian protein, in
particular the lysine triad, are also conserved (Fig. 8). This
extends the inference of a functional PPI binding domain
to these lower eukaryotes. Interestingly, the mammalian
AP-1 g, AP-3 d, and recently identified e subunit of a
novel AP-4 complex show distinct but considerably less
conservation of several of these basic residues (Fig. 8): to
the best of our knowledge the PPI binding properties of
these proteins have not been reported. Finally, the COPI
coatomer (Chaudhary et al., 1998) and AP180 (Ye et al.,
1995) also bind PPIs but have no discernible sequence similarity to AP-2 a. Collectively, these observations suggest
that PPI binding by coat subunits involved in membrane
transport is a ubiquitous phenomenon, and that the nature
of specific residues in this binding domain may impart
inositide binding specificity.
There is increasing evidence for an essential role of
phosphoinositides in transport vesicle function at different
locations in mammalian cells. Phosphoinositides, particularly PIP2, formed secondarily to ARF activation of phospholipase D, have been implicated in the recruitment of
COPI coat proteins onto the membranes of the Golgi
stacks (Donaldson et al., 1992; Palmer et al., 1993; Ktistakis et al., 1996). The specific interaction between these
acidic phospholipids and coatomer, which has been shown
to bind PPIs and particularly PIP3 with high affinity (Fleischer et al., 1994; Chaudhary et al., 1998), could contribute
to recruitment of the coatomer to a specific membrane location, though this is controversial (Stamnes et al., 1998).
With regard to AP-2, broken cell assays have shown that
PIP2 sequestration, accomplished either pharmacologically with neomycin or biochemically using the PH domain
of PLCd, had an inhibitory effect on AP-2 recruitment to
the plasma membrane, indirectly implicating phospho-

inositides in AP-2 targeting (West et al., 1997; Jost et al.,
1998).
Our in vitro binding data indicated that the (assembled)
coat form of AP-2 shows the highest affinity for phosphoinositides, as compared with inositol phosphates, and that
the converse is true for the soluble (disassembled) AP-2
protein (Beck and Keen, 1991; Gaidarov et al., 1996).
These observations suggest that the presence of phosphoinositides will drive the AP-2 molecule toward its higher
affinity, assembled form. This conjecture is supported by
the observation reported here that AP-2 lacking a functional PPI site is not incorporated into coated pits. Further, it has been reported that the receptor cytoplasmic tail
interaction of AP-2 with bound phosphoinositide is comparable to that with AP-2 in an assembled coat structure,
and that both are of higher affinity than that with free AP-2
(Rapoport et al., 1998), again suggesting that inositide
binding drives AP-2 toward an assembled conformation
thereby promoting its ability to interact with clathrin.
The results reported here provide direct support for the
notion that PPIs play a physiologically important role in
membrane recruitment of AP-2. The mutant AP-2PPI2 assayed in vitro is almost totally defective in PPI binding, but
otherwise indistinguishable from the wild-type protein by
multiple structural and functional criteria. However, in intact cells AP-2PPI2 is almost completely defective in incorporation into plasma membrane clathrin-coated pits. Unlike the wild-type protein, it tends to have a diffuse
distribution throughout the cell (Figs. 6 a and 7). At high
expression levels, a small amount of punctate signal is also
detectable which may reflect the inability of AP-2PPI2 to
bind PPIs and resist self-association (Beck and Keen,
1991). These observations are generally consistent with
earlier results of Page and Robinson (Page and Robinson,
1995). Using a/g chimeras, their results indicated that the
plasma membrane/Golgi targeting signals are localized
primarily between residues 130 and 330–350 in the a and g
sequences, respectively. Interestingly, chimeric proteins
in which 132, or even 36, residues from the NH2-terminal
region of the AP-2a subunit had been replaced by corresponding g sequences gave substantial diffuse signal and
considerably reduced, though still detectable, recruitment
to plasma membrane coated pits (for example see Page
and Robinson, 1995; Fig. 3, A and B). This may reflect
cooperation of the plasma membrane targeting signal, localized by these workers to the distal a sequence, with the
action of a hypothetical PPI binding domain in the NH2-

Figure 8. Basic residues involved in PPI binding in mammalian AP-2 a are highly conserved. Sequence alignments of mouse AP-2
a (Mouse a, accession number P17426) with
Drosophila melanogaster (Dm a, accession
number Y13092), Caenorhabditis elegans (Ce
a, accession number U28742), Saccharomyces
cerevisiae (Sc a, accession number P38065),
Schizosaccharomyces pombe (Sp a, accession
number AB004535), mouse g adaptin (mouse g, accession number X54424), human d (accession number AF002163), and human e
(I.M.A.G.E. Clone ID 1031294; Dell’Angelica, E., personal communication). Sequence comparisons were performed with PILEUP,
with numbering according to the mouse AP-2 a sequence. Residues identical to the mouse AP-2 a protein in four or more other sequences are highlighted on a black background; nonidentical but conserved residues in three or more sequences are shaded. Asterisks
denote basic residues critical to PPI binding in the AP-2 a sequence.
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terminal region of the g sequence (see above and Fig. 8).
According to this reasoning, the AP-2PPI2 is not detectably
recruited to coated pits despite presence of a plasma membrane targeting signal because it lacks PPI binding.
Interestingly, AP-2PPI2 also acts as a dominant-negative inhibitor of coated pit formation. This suggests that
excess inactive AP-2PPI2 complexes effectively sequester
the other AP-2 subunits and/or occupy the limited sites
that must be available for coat formation (Moore et al.,
1987; Santini et al., 1998; Gaidarov et al., 1999; Subtil et al.,
1999), indicating in either case that the binding to AP-2 of
PIP3 or another specific PPI ligand in the membrane is important early during the receptor mediated endocytosis
process, i.e., at the stage of clathrin-coated pit formation.
We have recently demonstrated that clathrin-coated pits
form at specific and defined sites on the plasma membrane, and that a cytoskeletal framework in tight association with the membrane likely plays a major organizational role in this process (Gaidarov et al., 1999).
Together, these results suggest a model in which coat formation is initiated and anchored by interactions oriented
both outward toward the plasma membrane and inward
toward a neighboring skeletal structure.
This general model is supported by our recent demonstration that PPIs are also involved in the ligand-dependent internalization of another class of receptors, the
G-protein–coupled receptors. Nonvisual arrestins, which
have been shown to act as adaptors in the internalization
of b2-adrenergic receptors (Ferguson et al., 1996; Goodman et al., 1996), bind PPIs with high affinity. We found
that soluble PPIs and phosphoinositides differentially
modulate arrestin interaction with clathrin and receptor.
Furthermore, as in the case of the AP-2 adaptor reported
here, a functional PPI binding site is critical to the liganddependent recruitment of the receptor-arrestin complex to
clathrin-coated pits (Gaidarov et al., 1999).
Together, these findings point to common themes of
phosphoinositide action in membrane trafficking events:
they may serve either as recruitment signals for coat components and/or to modulate the interaction of coat components with receptor complexes. The presence in clathrincoated pits and vesicles of synaptojanin (Haffne et al.,
1997), a phosphoinositide 5-phosphatase, suggests that
adaptor functions may be regulated by a complex interplay of different enzymes involved in site-specific phosphoinositide metabolism. Additional enzymes involved in
adaptor/coat regulation, and the factors, which modulate
their activity, are yet to be discovered.
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